Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127200831 | 12720083 | 1 | I | 20160830 | 20160901 | 20160907 | 20160907 | EXP | GB-009507513-1609GBR000731 | MERCK | 41.00 | YR | M | Y | 0.00000 | 20160907 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127200831 | 12720083 | 1 | PS | RALTEGRAVIR POTASSIUM | RALTEGRAVIR POTASSIUM | 1 | Oral | 400 MG | U | 22145 | TABLET | ||||||||
| 127200831 | 12720083 | 2 | SS | NORVIR | RITONAVIR | 1 | U | 0 | TABLET | ||||||||||
| 127200831 | 12720083 | 3 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | 800 MG | U | 0 | ||||||||||
| 127200831 | 12720083 | 4 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | U | 0 | TABLET |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127200831 | 12720083 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127200831 | 12720083 | Skin ulcer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |